{"id":"medical-nutrition-therapy-metformin","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Gastrointestinal disturbance (nausea, diarrhea, abdominal discomfort)"},{"rate":"3-10","effect":"Metallic taste"},{"rate":"10-30","effect":"Vitamin B12 deficiency (with long-term metformin use)"},{"rate":"<0.1","effect":"Lactic acidosis (rare)"}]},"_chembl":{"chemblId":"CHEMBL1431","moleculeType":"Small molecule","molecularWeight":"129.17"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Medical nutrition therapy (MNT) involves structured dietary intervention to improve metabolic control and weight management. Metformin, a biguanide, decreases hepatic glucose production and improves peripheral insulin sensitivity. Together, they address both nutritional and pharmacological aspects of glucose homeostasis.","oneSentence":"Medical nutrition therapy combined with metformin reduces blood glucose through dietary management and insulin sensitization, respectively.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:54:11.756Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Gestational diabetes mellitus (likely, given Instituto Nacional de Perinatologia focus)"},{"name":"Type 2 diabetes management"}]},"trialDetails":[{"nctId":"NCT07380841","phase":"NA","title":"Metformin vs Inositol vs Diet vs Combination Therapy in PCOS","status":"COMPLETED","sponsor":"Islamabad Medical and Dental College","startDate":"2025-05-21","conditions":"Polycystic Ovary Syndrome, Insulin Resistance, Metabolic Syndrome","enrollment":192},{"nctId":"NCT07336914","phase":"NA","title":"Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes","status":"RECRUITING","sponsor":"Khyber Medical University Peshawar","startDate":"2025-10-01","conditions":"Gestational Diabetes","enrollment":60},{"nctId":"NCT04691960","phase":"PHASE2","title":"A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2016-08","conditions":"Glioblastoma","enrollment":18},{"nctId":"NCT05183204","phase":"PHASE2","title":"Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma","status":"SUSPENDED","sponsor":"Weill Medical College of Cornell University","startDate":"2022-02-14","conditions":"Glioblastoma","enrollment":33},{"nctId":"NCT03603912","phase":"PHASE4","title":"Targeting Risk Interventions and Metformin for Atrial Fibrillation (TRIM-AF)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mina Chung, MD","startDate":"2018-08-24","conditions":"Atrial Fibrillation","enrollment":175},{"nctId":"NCT06682351","phase":"PHASE4","title":"Heterogeneity of Diabetes: Integrated Muli-Omics to Identify Physiologic Subphenotypes and Evaluate Targeted Prevention","status":"NOT_YET_RECRUITING","sponsor":"Stanford University","startDate":"2024-11","conditions":"Prediabetes / Type 2 Diabetes","enrollment":200},{"nctId":"NCT03558867","phase":"NA","title":"Personalised Medicine in Pre-diabetes and Early Type 2 Diabetes","status":"COMPLETED","sponsor":"Garvan Institute of Medical Research","startDate":"2018-06-05","conditions":"Pre Diabetes, Type 2 Diabetes Mellitus","enrollment":138},{"nctId":"NCT05702905","phase":"PHASE4","title":"Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome","status":"RECRUITING","sponsor":"Peking University First Hospital","startDate":"2023-05-09","conditions":"PCOS (Polycystic Ovary Syndrome), Semaglutide","enrollment":75},{"nctId":"NCT06049186","phase":"NA","title":"CRD vs. Met in Patients With Obese PCOS Infertility","status":"RECRUITING","sponsor":"Shanghai First Maternity and Infant Hospital","startDate":"2023-09-15","conditions":"Polycystic Ovary Syndrome","enrollment":406},{"nctId":"NCT00139477","phase":"NA","title":"Study of Serum Markers for Cardiovascular Risk in Obese Youth and Impact of Lifestyle and Medication Intervention","status":"COMPLETED","sponsor":"Nemours Children's Clinic","startDate":"2003-11","conditions":"Obesity","enrollment":66},{"nctId":"NCT04175964","phase":"NA","title":"Role of the Ketogenic Diet in Women With PCOS","status":"UNKNOWN","sponsor":"National Research Centre, Egypt","startDate":"2022-12-01","conditions":"Polycystic Ovary Syndrome","enrollment":240},{"nctId":"NCT01482286","phase":"PHASE3","title":"Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS","status":"TERMINATED","sponsor":"Pennington Biomedical Research Center","startDate":"2012-05","conditions":"Polycystic Ovary Syndrome","enrollment":32},{"nctId":"NCT02708758","phase":"NA","title":"Efficacy of Treatment for Gestational Diabetes Diagnosed by the IADPSG Criteria.","status":"UNKNOWN","sponsor":"Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes","startDate":"2016-03","conditions":"Gestational Diabetes","enrollment":400},{"nctId":"NCT03877783","phase":"NA","title":"DEMAND - Multifactorial Study to Reduce Dementia in People With Type 2 Diabetes","status":"UNKNOWN","sponsor":"Umeå University","startDate":"2020-10-19","conditions":"Type 2 Diabetes Mellitus, Mild Cognitive Impairment","enrollment":10},{"nctId":"NCT02019979","phase":"PHASE2","title":"Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC)","status":"TERMINATED","sponsor":"Beth Israel Medical Center","startDate":"2013-12","conditions":"Non-small Cell Lung Cancer Stage IIIB/IV, Non-small Cell Lung Cancer Metastatic, Nonsquamous Nonsmall Cell Neoplasm of Lung","enrollment":14},{"nctId":"NCT02149459","phase":"PHASE1","title":"Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With Radiotherapy","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2014-06","conditions":"Brain Neoplasms","enrollment":18},{"nctId":"NCT02269098","phase":"NA","title":"The Synergy to Control Emergency Department Hyperglycemia Program for Type 2 Diabetes","status":"COMPLETED","sponsor":"Medstar Health Research Institute","startDate":"2012-02","conditions":"Diabetes Mellitus, Type 2, Medication Adherence, HYPERGLYCEMIA","enrollment":101},{"nctId":"NCT02745886","phase":"PHASE4","title":"Metformin Induces a Dietary Restriction-like State in Human","status":"UNKNOWN","sponsor":"Xiang Guang-da","startDate":"2016-04","conditions":"Overweight Subjects, Metformin, Aging","enrollment":60},{"nctId":"NCT01675310","phase":"PHASE4","title":"Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women","status":"COMPLETED","sponsor":"Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes","startDate":"2012-01","conditions":"Pregestational Obesity (BMI > 27kg/m2), History of Polycystic Ovary Syndrome","enrollment":90},{"nctId":"NCT01107808","phase":"NA","title":"Calcium, Vitamin D and Metformin to Treat Insulin Resistance in Obese African American Adolescent Females","status":"WITHDRAWN","sponsor":"University of Alabama at Birmingham","startDate":"2009-06","conditions":"Insulin Resistance, Insulin Sensitivity, Obesity","enrollment":""},{"nctId":"NCT01765894","phase":"","title":"Influence of Moderate Exercise on Blood Glucose in Type 2 Diabetics and Healthy Controls","status":"COMPLETED","sponsor":"University of Copenhagen","startDate":"2012-10","conditions":"Type 2 Diabetes and Exercise","enrollment":24},{"nctId":"NCT01125150","phase":"","title":"Spectroscopic and Colorimetric Analysis of Acanthosis Nigricans in Patients With Hyperinsulinemia","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2009-02","conditions":"Acanthosis Nigricans, Hyperinsulinemia, Spectroscopic Analysis","enrollment":9}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"medical nutrition therapy + metformin","genericName":"medical nutrition therapy + metformin","companyName":"Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes","companyId":"instituto-nacional-de-perinatologia-isidro-espinosa-de-los-reyes","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Medical nutrition therapy combined with metformin reduces blood glucose through dietary management and insulin sensitization, respectively. Used for Gestational diabetes mellitus (likely, given Instituto Nacional de Perinatologia focus), Type 2 diabetes management.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}